LT2005087A - Vakcinos kompozicijos gangliozido pagrindu, skirtos įvedimui po oda - Google Patents
Vakcinos kompozicijos gangliozido pagrindu, skirtos įvedimui po odaInfo
- Publication number
- LT2005087A LT2005087A LT2005087A LT2005087A LT2005087A LT 2005087 A LT2005087 A LT 2005087A LT 2005087 A LT2005087 A LT 2005087A LT 2005087 A LT2005087 A LT 2005087A LT 2005087 A LT2005087 A LT 2005087A
- Authority
- LT
- Lithuania
- Prior art keywords
- vssp
- vaccine compositions
- ganglioside
- subcutaneously
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000002270 gangliosides Chemical class 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 108010030416 proteoliposomes Proteins 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/001171—Gangliosides, e.g. GM2, GD2 or GD3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
Aprašytos vakcinos kompozicijos, kuriose gangliozidai ir N. meningitidis OMP buvo sujungti, suformuojant labai mažo dydžio proteoliposomas (VSSP), skirtas įvedimui po oda. Šios kompozicijos nereikalauja bet kokių papildomų adjuvantų naudojimo. Aprašytos kompozicijos įgalina pranašesnį imunologinį gydymą gangliozidais, dalinai N-AcGM3/VSSP ir N-GcGM3/VSSP, injekcijos vietoje sukeliant mažiau agresyvią reakciją. Šias vakcinos kompozicijas galima naudoti paprastesniu būdu ir sveikesniu pacientams.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20030047A CU23257A1 (es) | 2003-02-27 | 2003-02-27 | COMPOSICIONES VACUNALES A BASE DE GANGLIOSIDOS PARA LA ADMINISTRACION SUBCUTáNEA |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LT2005087A true LT2005087A (lt) | 2006-04-25 |
| LT5351B LT5351B (lt) | 2006-07-25 |
Family
ID=40091613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LT2005087A LT5351B (lt) | 2003-02-27 | 2005-09-21 | Vakcinos kompozicijos gangliozido pagrindu, skirtos įvedimui po oda |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US8591917B2 (lt) |
| EP (1) | EP1604683B1 (lt) |
| JP (1) | JP4729475B2 (lt) |
| KR (1) | KR100703570B1 (lt) |
| CN (1) | CN100418576C (lt) |
| AR (1) | AR043377A1 (lt) |
| AT (1) | ATE353668T1 (lt) |
| AU (1) | AU2004216554B2 (lt) |
| BR (1) | BRPI0407854B1 (lt) |
| CA (1) | CA2535214C (lt) |
| CL (1) | CL2004000374A1 (lt) |
| CR (1) | CR7965A (lt) |
| CU (1) | CU23257A1 (lt) |
| CY (1) | CY1106668T1 (lt) |
| DE (1) | DE602004004768T2 (lt) |
| DK (1) | DK1604683T3 (lt) |
| EA (1) | EA008905B1 (lt) |
| EC (1) | ECSP055978A (lt) |
| EG (1) | EG26446A (lt) |
| ES (1) | ES2280948T3 (lt) |
| GE (1) | GEP20074120B (lt) |
| HR (1) | HRP20050763A2 (lt) |
| IL (1) | IL170355A (lt) |
| LT (1) | LT5351B (lt) |
| LV (1) | LV13400B (lt) |
| MY (1) | MY139811A (lt) |
| NZ (1) | NZ541952A (lt) |
| PE (1) | PE20040955A1 (lt) |
| PT (1) | PT1604683E (lt) |
| RS (1) | RS20050664A (lt) |
| SI (1) | SI1604683T1 (lt) |
| TN (1) | TNSN05209A1 (lt) |
| TW (1) | TWI344372B (lt) |
| UA (1) | UA80859C2 (lt) |
| UY (1) | UY28207A1 (lt) |
| WO (1) | WO2004075811A2 (lt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU24534B1 (es) * | 2017-11-06 | 2021-07-02 | Ct Inmunologia Molecular | Adyuvantes nano-particulados que contienen variantes sintéticas del gangliósido gm3 |
| CU20170173A7 (es) | 2017-12-27 | 2019-11-04 | Ct Inmunologia Molecular | Nano-partículas que contienen el gangliósido gm3 como inmunomoduladoras |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965198A (en) | 1985-12-24 | 1990-10-23 | Konica Corporation | Monoclonal antibody and method of manufacturing hybridoma producing the same |
| CU22420A1 (es) * | 1993-12-29 | 1996-01-31 | Centro Inmunologia Molecular | Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer |
| US6149921A (en) * | 1993-12-29 | 2000-11-21 | Centro De Inmunologia Molecular | Vaccine compositions for eliciting an immune response against N-acetylated gangliosides and their use for cancer treatment |
| PE20020572A1 (es) * | 2000-12-06 | 2002-07-31 | Centro Inmunologia Molecular | Preparaciones para potenciar la inmunogenicidad de antigenos poco inmunogenicos |
| US20030108574A1 (en) * | 2001-08-21 | 2003-06-12 | Jennings Harold J. | Carbohydrate-based whole cell cancer vaccines |
-
2003
- 2003-02-27 CU CU20030047A patent/CU23257A1/es unknown
-
2004
- 2004-02-24 AR ARP040100571A patent/AR043377A1/es not_active Application Discontinuation
- 2004-02-24 PE PE2004000186A patent/PE20040955A1/es not_active Application Discontinuation
- 2004-02-25 TW TW093104808A patent/TWI344372B/zh not_active IP Right Cessation
- 2004-02-26 MY MYPI20040641A patent/MY139811A/en unknown
- 2004-02-26 CL CL200400374A patent/CL2004000374A1/es unknown
- 2004-02-27 BR BRPI0407854-3A patent/BRPI0407854B1/pt not_active IP Right Cessation
- 2004-02-27 UA UAA200508381A patent/UA80859C2/xx unknown
- 2004-02-27 NZ NZ541952A patent/NZ541952A/en not_active IP Right Cessation
- 2004-02-27 EP EP04715239A patent/EP1604683B1/en not_active Expired - Lifetime
- 2004-02-27 CN CNB2004800052015A patent/CN100418576C/zh not_active Expired - Lifetime
- 2004-02-27 HR HR20050763A patent/HRP20050763A2/hr not_active Application Discontinuation
- 2004-02-27 WO PCT/CU2004/000003 patent/WO2004075811A2/es active IP Right Grant
- 2004-02-27 AT AT04715239T patent/ATE353668T1/de active
- 2004-02-27 EA EA200501367A patent/EA008905B1/ru not_active IP Right Cessation
- 2004-02-27 PT PT04715239T patent/PT1604683E/pt unknown
- 2004-02-27 SI SI200430262T patent/SI1604683T1/sl unknown
- 2004-02-27 ES ES04715239T patent/ES2280948T3/es not_active Expired - Lifetime
- 2004-02-27 RS YUP-2005/0664A patent/RS20050664A/sr unknown
- 2004-02-27 DE DE602004004768T patent/DE602004004768T2/de not_active Expired - Lifetime
- 2004-02-27 US US10/547,164 patent/US8591917B2/en active Active
- 2004-02-27 DK DK04715239T patent/DK1604683T3/da active
- 2004-02-27 UY UY28207A patent/UY28207A1/es unknown
- 2004-02-27 CA CA2535214A patent/CA2535214C/en not_active Expired - Lifetime
- 2004-02-27 KR KR1020057015531A patent/KR100703570B1/ko not_active Expired - Lifetime
- 2004-02-27 JP JP2006501455A patent/JP4729475B2/ja not_active Expired - Lifetime
- 2004-02-27 AU AU2004216554A patent/AU2004216554B2/en not_active Expired
- 2004-02-27 GE GEAP20048952A patent/GEP20074120B/en unknown
-
2005
- 2005-08-18 IL IL170355A patent/IL170355A/en not_active IP Right Cessation
- 2005-08-20 EG EGPCTNA2005000479A patent/EG26446A/en active
- 2005-08-24 EC EC2005005978A patent/ECSP055978A/es unknown
- 2005-08-26 TN TNP2005000209A patent/TNSN05209A1/en unknown
- 2005-08-26 CR CR7965A patent/CR7965A/es unknown
- 2005-08-29 LV LVP-05-110A patent/LV13400B/en unknown
- 2005-09-21 LT LT2005087A patent/LT5351B/lt not_active IP Right Cessation
-
2007
- 2007-04-26 CY CY20071100556T patent/CY1106668T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009008928A (es) | Composiciones que comprenden conjugados de polisacaridos y su uso como vacunas. | |
| RU2378009C2 (ru) | Иммунизация против менингококков серогруппы y с помощью белков | |
| CR10123A (es) | Vacuna. | |
| MX2009001412A (es) | Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas. | |
| UA105210C2 (ru) | Противораковая вакцина и ее применение | |
| MX2010012999A (es) | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. | |
| AP1763A (en) | Pulmonary administration of chemically modified insulin | |
| MX2008004734A (es) | Composicion rica en leucina. | |
| MY169275A (en) | Method of immunization against the four serotypes of dengue | |
| SG169228A1 (en) | Biocompatible dialysis fluids containing icodextrins | |
| PE20040562A1 (es) | Vacunas que comprenden mezclas de cepas meningococicas multivalentes | |
| WO2011156774A3 (en) | Multivalent glycopeptide constructs and uses thereof | |
| NZ515936A (en) | Antigenic Neisserial peptides | |
| NO20076446L (no) | Beholder med hulmal | |
| NO20082098L (no) | Formuleringer av AICA-ribosid | |
| CY1108138T1 (el) | Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι | |
| DK1869185T3 (da) | Konjugat med P21-protein til kræftbehandling | |
| LT2005087A (lt) | Vakcinos kompozicijos gangliozido pagrindu, skirtos įvedimui po oda | |
| WO2010039924A3 (en) | Th1 vaccination priming for active immunotheraphy | |
| BR112013010338A2 (pt) | composição, métodos para preparar uma composição imunogênica, para adjuvantar uma resposta imune, para eliciar uma resposta imune contra um agente infeccioso, para evitar e/ou reduzir a deposição de amilóide ou doença de alzheimer em um indivíduo, e para tratar/reduzir/melhorar a infecção por uma agente infeccioso, uso de uma proteína, e, kit | |
| BRPI0412506A (pt) | células autólogas que induzem à autotoleráncia de origem monocìtica e seu uso em preparações farmacêuticos | |
| NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella | |
| WO2023014562A3 (en) | Alleviating drug nephrotoxicity | |
| WO2005023295A3 (en) | Naturally processed immunodominant peptides derived from neisseria meningitidis porin a protein and their use | |
| NO20083318L (no) | Farmasoytiske sammensetninger inneholdende protein NMA0939 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM9A | Lapsed patents |
Effective date: 20130227 |